181 related articles for article (PubMed ID: 23936528)
1. Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.
He H; Wang C; Shen Z; Fang Y; Wang X; Chen W; Liu F; Qin X; Sun Y
PLoS One; 2013; 8(8):e71864. PubMed ID: 23936528
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer.
Wang X; He H; Zhang H; Chen W; Ji Y; Tang Z; Fang Y; Wang C; Liu F; Shen Z; Qin J; Zhu Y; Liu H; Xu J; Gu J; Qin X; Sun Y
Cancer Sci; 2013 Feb; 104(2):185-93. PubMed ID: 23107376
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer.
He H; Shen Z; Zhang H; Wang X; Tang Z; Xu J; Sun Y
Br J Cancer; 2014 Apr; 110(8):2021-9. PubMed ID: 24619076
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection.
Cao Y; Liu H; Zhang H; Lin C; Li R; Zhang W; Shen Z; Xu J
Tumour Biol; 2016 Aug; 37(8):10883-91. PubMed ID: 26883254
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy.
Gu Q; Zhang J; Hu H; Tan YE; Shi S; Nian Y
PLoS One; 2015; 10(11):e0142377. PubMed ID: 26545111
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of MiR-34a Expression in Patients with Gastric Cancer after Radical Gastrectomy.
Hui WT; Ma XB; Zan Y; Wang XJ; Dong L
Chin Med J (Engl); 2015 Oct; 128(19):2632-7. PubMed ID: 26415802
[TBL] [Abstract][Full Text] [Related]
7. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer.
Xue S; Ma M; Bei S; Li F; Wu C; Li H; Hu Y; Zhang X; Qian Y; Qin Z; Jiang J; Feng L
Front Immunol; 2021; 12():702615. PubMed ID: 34322132
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
Jiang Q; Sun Y; Liu X
Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
[No Abstract] [Full Text] [Related]
10. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Chemokine CXCL-12 and ist Receptor CXCR4 Expression is Associated with Clinical Prognosis of Gastric Cancer.
Xu G; Lu K; Shen M; Zhang Q; Pan W; Tang Z
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255293
[TBL] [Abstract][Full Text] [Related]
13. CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.
Li L; Fu LQ; Wang HJ; Wang YY
Pathol Oncol Res; 2020 Jan; 26(1):273-279. PubMed ID: 30047046
[TBL] [Abstract][Full Text] [Related]
14. Expression of chemokine receptors in human gastric cancer.
Kwak MK; Hur K; Park DJ; Lee HJ; Lee HS; Kim WH; Lee KU; Choe KJ; Yang HK
Tumour Biol; 2005; 26(2):65-70. PubMed ID: 15867478
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer.
Lin Q; Wei Y; Zhong Y; Zhu D; Ren L; Xu P; Zheng P; Feng Q; Ji M; Lv M; Liang C; Xu J
Tumour Biol; 2014 Oct; 35(10):9743-50. PubMed ID: 24972972
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of C-X-C motif chemokine receptor 4 in patients with sporadic malignant peripheral nerve sheath tumors.
Zhang C; Chang FY; Zhou WY; Yang JL
Chin J Cancer; 2017 Oct; 36(1):80. PubMed ID: 29020982
[TBL] [Abstract][Full Text] [Related]
17. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.
Ying J; Xu Q; Zhang G; Liu B; Zhu L
Med Oncol; 2012 Sep; 29(3):1716-22. PubMed ID: 21630055
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of C-C motif ligand 2 associates with poor prognosis in patients with gastric cancer after gastrectomy.
Liu H; Shen Z; Wang X; Zhang H; Qin J; Qin X; Xu J; Sun Y
Tumour Biol; 2016 Mar; 37(3):3285-93. PubMed ID: 26438062
[TBL] [Abstract][Full Text] [Related]
19. Combined Evaluation of Expression of CXCR4 and Nrf2 as Prognostic Factor for Patients with Gastric Carcinoma.
Yu S; Wu T; Wang J; Cheng C; Wang J; Sun L; Liu C; Cao G; Hu T
Anticancer Agents Med Chem; 2018; 18(3):388-393. PubMed ID: 29110625
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
